Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,156.00
Bid: 12,124.00
Ask: 12,128.00
Change: -14.00 (-0.12%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sunday newspaper round-up: AstraZeneca, Boxing Day, Britain's economy

Sun, 27th Dec 2020 12:39

(Sharecast News) - The chief executive of AstraZeneca has raised hopes its vaccine with Oxford is more effective than first thought amid the rapid spread of the new UK virus strain across the globe. Pascal Soriot said he believed researchers had found the "winning formula" using two doses and promised to publish the results as reports suggested the UK regulator could approve the jab within days. - Sunday Telegraph

Footfall at the Boxing Day sales was down by more than half on last year as non-essential retail remained closed in much of the country under tightened coronavirus restrictions. While queues were seen outside shops in areas under tiers 2 and 3, high streets in the 43% of England that is under tier 4 were empty. The retail intelligence agency Springboard said Boxing Day footfall in the UK up to 10am was down 57% compared with last year. - Guardian

Britain's economy will outperform European rivals such as France over the next 15 years, according to morale-boosting forecasts published in the wake of the Government's Brexit trade deal with Brussels. A new ranking shows the UK remaining the world's 5th biggest economy next year. From 2025 it slips one place, but still performs better than many peer western economies. The UK's economy will be 23pc larger than that of France by 2035, the Centre for Economics and Business Research (CEBR) predicts. - Sunday Telegraph

The car industry is in a race against time to build giant battery gigafactories in the UK to ensure its survival and avoid damaging tariffs from the Brexit trade deal. Details of the EU deal revealed that Britain has a six-year window to build its supply of electric vehicle parts - either domestically or from the Continent - if it wants to continue selling them tariff-free to Europe. - Sunday Times

Bankers are gearing up for a surge of flotations on the London Stock Exchange next year as companies that delayed listing their shares due to the pandemic press ahead with plans to tap public markets. Dealmakers said they expect a boom in initial public offerings (IPOs) driven by pent up demand after pandemic disruption effectively halted new listings for much of 2020. Advisers predicted increased investor appetite for tech and healthcare firms that have done well in the crisis. - Sunday Telegraph

More than three-quarters of MPs are expected to dial in remotely to a debate that will consider the government's Brexit deal on Wednesday. The majority of MPs are preparing to participate online after the Commons speaker urged them to stay at home and made it clear those present in person will not be given priority to speak. Both the Commons and the Lords will sit for a single day on December 30 to pass the Future Relationship Bill implementing the government's free trade deal with the EU. - Sunday Times

Industry figures are calling on EU leaders to urgently agree a Brexit "adjustment period" after negotiators left them with just three working days to prepare for the end of the Brexit transition period. While big business including manufacturers and supermarkets have made Brexit preparations costing hundreds of millions of pounds, they say there is not enough time over Christmas to implement the newly agreed trading regime. - Guardian

The Bank of England could pull the trigger on negative interest rates if strict coronavirus restrictions are extended well into the new year, leading economists have warned. Interest rates are at record lows of 0.1%, leaving rate-setters with little room to move and raising the prospect of negative rates in the UK for the first time. - Sunday Times

City veteran Keith Skeoch has been appointed by the Treasury to lead a review of banking regulations in what could be the biggest overhaul of the sector since the fallout of the financial crisis a decade ago. The former chief executive of Standard Life Aberdeen will revisit the stringent rules put in place to rein in banks after several were bailed out by the Government in 2008, including Royal Bank of Scotland, Lloyds TSB and HBOS. - Financial Mail on Sunday
More News
8 Feb 2024 07:50

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.

Read more
2 Feb 2024 08:38

AstraZeneca celebrates latest successful trial of acoramidis in Japan

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.

Read more
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.